Skip to main content
SpringerLink
Log in

Fractionated Radiosurgery for Brain Metastases in 43 Patients with Breast Carcinoma

  • Conference Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

About 15% of metastatic breast carcinoma patients are diagnosed with brain metastases. Historically, the majority are treated with palliative external whole-brain radiation with a median survival of 4 months. We examined stereotactic radiosurgery's effect on treatment outcome in such patients. Four hundred and fifty four consecutive patients with brain metastases were treated with stereotactic radiosurgery at Staten Island University Hospital, NY, between 1991 and 1999. The medical records of 60 women with histologically confirmed breast cancer were retrospectively reviewed. Forty-three patients (71%) received fractionated radiosurgery (4×600cGy) and form the core of this report. Sixty five percentage had been previously unsuccessfully treated by whole-brain radiation or had recurrence after craniotomy. Survival was calculated by the Kaplan–Meier method. The median age at diagnosis of brain metastases was 52 years, with median interval of 49 months following the diagnosis of tumor primary. Median survival from brain diagnosis reached 13.6 months. Overall median survival from radiosurgery treatment was 7.5 months. Fifteen patients with one or two brain lesions survived a median of 11.5 months. For the fractionated cohort of patients 1- and 2-year actuarial survival was 28.2% and 12.8%, respectively. Three patients are alive at 32, 34 and 64 months, respectively. We conclude that fractionated radiosurgery improves survival of patients with brain metastases from breast cancer, especially those with small lesions, good functional status and no other metastatic disease. These patients should be encouraged to consider radiosurgery, possibly before WBRT. Considering our 7.5 months overall survival including patients with multiple metastases, and patients with progressive brain metastases despite extensive standard therapy and often systemic disease, these results suggest that radiosurgery could benefit breast cancer patients with brain metastases and extend life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. DiStefano A, Yap HJ, Hortobagyi GN, Blumenschein GR: The natural history of breast cancer patients with brain metastases. Cancer 44: 1913-1918, 1979

    Google Scholar 

  2. Boogerd W, Vos VW, Hart AA, Baris G: Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neuro-Oncol 15: 165-174, 1993

    Google Scholar 

  3. Carty NJ, Foggitt A, Hamilton CR, Royle GT, Taylor I: Patterns of clinical metastasis in breast cancer: an analysis of 100 patients. Europ J Surg Oncol 21: 607-608, 1995

    Google Scholar 

  4. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc PH, Dorval T, Durand JC, Fourquet A, Pouillart P: Infiltrating lobular carcinoma of the breast: clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 77: 113-120, 1996

    Google Scholar 

  5. Dethy S, Piccart MJ, Paesmans M, vanHoutte P, Klastersky J: History of brain and epidural metastases from breast cancer in relation with the disease evolution outside the central nervous system. Eur Neurol 35: 38-42, 1995

    Google Scholar 

  6. Pieper DR, Hess KR, Sawaya RE: Role of surgery in the treatment of brain metastases in patients with breast cancer. Ann Surg Oncol 4: 481-490, 1997

    Google Scholar 

  7. Wro´ński M, Arbit E, McCormack B: Surgical treatment of 70 patients with brain metastases from breast carcinoma. Cancer 80: 1746-1754, 1997

    Google Scholar 

  8. Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman M, Shaw EG, Hudgins WR, Weiner R, Harsh GR, Sneed PK, Larson DA: A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28: 797-802, 1994

    Google Scholar 

  9. Schöggel A, Kitz K, Ertl A, Dieckmann K, Saringer W, Koos WT: Gamma-knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients. Acta Neurochir 140: 549-555, 1998

    Google Scholar 

  10. Mori Y, Kondziolka D, Flickinger JC, Logan T, Lunsford LD: Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 83: 344-353, 1998

    Google Scholar 

  11. Seung SK, Shu HK, McDermott MW, Sneed PK, Larson DA.: Stereotactic radiosurgery for malignant melanoma to the brain. Surg Clin North Am 76: 1399-1411, 1996

    Google Scholar 

  12. Williams J, Enger Ch, Wharam M, Tsai D, Brem H: Stereotactic radiosurgery for brain metastases: comparison of lung carcinoma vs non-lung tumors. J Neuro-Oncol 37: 79-85, 1998

    Google Scholar 

  13. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958

    Google Scholar 

  14. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1-39, 1977

    Google Scholar 

  15. Boogerd W, Hart AA, Tjahja IS: Treatment and outcome of brain metastasis as first site of distant metastasis from breast cancer. J Neuro-Oncol 35: 161-167, 1997

    Google Scholar 

  16. Wronski M, Arbit E: Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 93: 9-18, 2000

    Google Scholar 

  17. Holmes FA: Update: theM.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma. Semin Oncol 22 (4 Suppl 8): 9-15, 1995

    Google Scholar 

  18. Sparano JA, Neuberg D, Glick JH, Robert NJ, Goldstein LJ, Sledge GW, Wood W: Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study. J Clin Oncol 15: 1880-1884, 1997

    Google Scholar 

  19. Pierga JY, Jouve M, Asselain B, Livartowski A, Beuzeboe P, Dieras V, Scholl S, Dorval T, Palangie T, Garcia-Giralt E, Pouillart P: Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90). Br J Cancer 77: 1474-1479, 1998

    Google Scholar 

  20. Haller DG, Fox KR, Schuchter LM: Metastatic breast cancer. In: Fowble B, Goodman RL, Glick JH, Rosato EF (eds) Breast Cancer Treatment: A Comprehensive Guide to Management. Mosby Year Book, St. Louis, 1991, pp 403-454

    Google Scholar 

  21. Flowers A, Levin VA: Management of brain metastases from breast carcinoma. Oncology (Williston Park, NY) 7: 21-26, 1993

    Google Scholar 

  22. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF: Intracerebral metastases in solid tumor patients. Natural history and results of treatment. Cancer 48: 384-394, 1981

    Google Scholar 

  23. Boogerd W, Hart AA, van der Sande JJ, Engelsman E: Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 67: 1685-1695, 1991

    Google Scholar 

  24. Pladdet I, Boven E, Nauta J, Pinedo HM: Palliative care for bra in metastases of solid tumour types. Neth JMed 34: 10-21, 1989

    Google Scholar 

  25. Lentzsch S, Reichardt P, Weber F, Budach V, Dörken B: Brain metastases in breast cancer: prognostic factors and management. Europ J Cancer 35: 580-585, 1999

    Google Scholar 

  26. Van der Steen-Banasik E, Hermans J, Tjho-Heslinga R, Caspers R, Leer JW: The objective response of brain metastases on radiotherapy. Acta Oncol 31: 777-780, 1992

    Google Scholar 

  27. Alexander E III, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Institute 87: 34-40, 1995

    Google Scholar 

  28. Mehta MP, Boyd TS, Sinha P: The status of stereotactic radiosurgery for cerebral metastases in 1998. J Radiosurg 1: 17-30, 1998

    Google Scholar 

  29. Kocher M, Voges J, Müller R-P, Sturm V, Müller J, Staar S, Lehrke R: LINAC radiosurgery for patients with a limited number of brain metastases. J Radiosurg 1: 9-15, 1998

    Google Scholar 

  30. Mehta M, Noyes W, Craig B, Lamond J, Auchter R, French M, Johnson M, Levin A, Badie B, Robbins I, Kinsella T: A cost-effectiveness and cost-utility analysis of radiosurgery vs resection for single-brain metastases. Int J Radiat Oncol Biol Phys 39: 445-454, 1997

    Google Scholar 

  31. Firlik K, Kondziolka D, Flickinger JC, Lunsford DL: Stereotactic radiosurgery for brain metastases from breast cancer. Ann Surg Oncol 7: 333-338, 2000

    Google Scholar 

  32. Shiau CY, Sneed PK, Shu HKG, Lamborn KR, McDermott MW, Chang S, Nowak P, Petti PL, Smith V, Verhey LJ, Ho M, Park E, Wara WM, Gutin PhH, Larson DA: Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 37: 375-383, 1997

    Google Scholar 

  33. Breneman JC, Warnick RE, Albright RE Jr, Kukiatinant N, Shaw J, Armin D, Tew J Jr: Stereotactic radiosurgery for the treatment of brain metastases. Results of a single institution series. Cancer 79: 551-557, 1997

    Google Scholar 

  34. Joseph J, Adler JR, Cox RS, Hancock SL: Linear-acceleratorbased stereotaxic radiosurgery for brain metastases: the in-fluence of number of lesions on survival. J Clin Oncol 14: 1085-1092, 1996

    Google Scholar 

  35. Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Noyes WR, Schultz CJ, Loeffler JS, Mehta MP: A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 35: 27-35, 1996

    Google Scholar 

  36. Shirato H, Takamura A, Tomita M, Suzuki K, Nishioka T, Isu T, Kato T, Sawamura Y, Miyamachi K, Abe H, Miyasaka K: Stereotactic irradiation without whole-brain irradiation for single brain metastasis. Int J Radiat Oncol Biol Phys 37: 385-391, 1997

    Google Scholar 

  37. Patchell RA, Tibbs PhA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B: Postoperative radiotherapy in the treatment of single metastases to the brain. A randomized trial. JAMA 280: 1485-1489, 1998

    Google Scholar 

  38. Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, Gutin PH, Phillips TL, Wara WM, Larson DA: Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43: 549-558, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Director, Department Radiation Oncology, Staten Island University Hospital, New York, NY, USA

    Gilbert Lederman

  2. Director, Neuro-Oncology Research, Staten Island University Hospital, New York, NY, USA

    Marek Wronski

  3. Attending, Department of Radiology, Staten Island University Hospital, New York, NY, USA

    Martin Fine

Authors
  1. Gilbert Lederman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marek Wronski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Fine
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lederman, G., Wronski, M. & Fine, M. Fractionated Radiosurgery for Brain Metastases in 43 Patients with Breast Carcinoma. Breast Cancer Res Treat 65, 145–154 (2001). https://doi.org/10.1023/A:1006490200335

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006490200335

Search

Navigation